A detailed history of Vanguard Group Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Vanguard Group Inc holds 18,272,433 shares of TECH stock, worth $1.41 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,272,433
Previous 18,228,210 0.24%
Holding current value
$1.41 Billion
Previous $1.41 Billion 8.55%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$65.98 - $77.09 $2.92 Million - $3.41 Million
44,223 Added 0.24%
18,272,433 $1.29 Billion
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $6.68 Million - $9.89 Million
-126,459 Reduced 0.69%
18,228,210 $1.41 Billion
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $124,641 - $165,069
-1,846 Reduced 0.01%
18,354,669 $1.25 Billion
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $5.53 Million - $6.44 Million
-74,938 Reduced 0.41%
18,356,515 $1.5 Billion
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $16.6 Million - $20.1 Million
232,021 Added 1.27%
18,431,453 $1.37 Billion
Q4 2022

Feb 10, 2023

BUY
$80.67 - $352.29 $1.11 Billion - $4.83 Billion
13,711,690 Added 305.54%
18,199,432 $1.51 Billion
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $7.74 Million - $10.7 Million
27,397 Added 0.61%
4,487,742 $1.27 Billion
Q2 2022

Aug 12, 2022

BUY
$322.67 - $449.65 $4.87 Million - $6.78 Million
15,080 Added 0.34%
4,460,345 $1.55 Billion
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $6.59 Million - $9.09 Million
18,627 Added 0.42%
4,445,265 $1.92 Billion
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $27.5 Million - $31.7 Million
60,310 Added 1.38%
4,426,638 $2.29 Billion
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $282 Million - $341 Million
633,147 Added 16.96%
4,366,328 $2.12 Billion
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $1.45 Billion - $1.68 Billion
3,733,181 New
3,733,181 $1.68 Billion

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.03B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.